Carlos Buchpiguel

Full Professor Department of Radiology and Oncology - University of São Paulo

[Falha de S.Paulo @foIha_sp]

URGENTE: Jair Bolsonaro rouba avião da FAB e joga míssil de ovos teleguiados na casa do ministro Moraes

[Carlos Buchpiguel @buchpiguel]

@PeterMacCC @nhmrc @PrDavidBowtell @DrMHofman @Shahneen3 Congrats!!!!!

[Carlos Buchpiguel @buchpiguel]

@PeterMacCC Congrats Prof. Hofman and Peter Mac Câncer Center

[Carlos Buchpiguel @buchpiguel]

@herneygarcia @RafaelFCoelho2 @DiogoAssed @jeanlestingi @qdtrinh Grande conquista. Parabéns @RafaelFCoelho2 @DiogoAssed e demais coautores.

[Carlos Buchpiguel @buchpiguel]

@DrMHofman Great news. Important to move forward and also to include the Lutetium-177 PSMA-617 in the major clinical gidelines.

[Carlos Buchpiguel @buchpiguel]

@CarcinoidNETs @DrMHofman Really interesting @CarcinoidNETs and @DrMHofman . However , it is important to develop a fase II/III clinical trial to move forward for a global utilization and implementation of this new formulation into PRRT. Great news.

[Carlos Buchpiguel @buchpiguel]

@DrMHofman @PCF_Science Indeed @DrMHofman Great review and wonderful group of experts.

[Carlos Buchpiguel @buchpiguel]

https://t.co/k9YPqHwW4t

[Carlos Buchpiguel @buchpiguel]

Z g https://t.co/51ZhlpxfQv bhh-mas-edicao-continua-incerta/z6zv

[Carlos Buchpiguel @buchpiguel]

Sds6zzsz6 https://t.co/k9YPqHwW4t

[PCF Science @PCF_Science]

WEBINAR! @pros_tic-@PCFnews TheraP DEEP DIVE Global Knowledge Exchange Webinar: On the phase 2 randomised trial of Lu-177 PSMA-617 vs cabazitaxel in men with castration-resistant #ProstateCancer.

Feb 24 @ 3-4:20pm ET / Feb 25 @ 7-8:20am AEDT

REGISTER: https://t.co/fM0H0NcxBf

[Carlos Buchpiguel @buchpiguel]

Breaktrough trial with striking results. Congrats @DrMHofman and team.

[Thomas Hope @thomashopemd]

Congrats to @DrMHofman and @ANZUPtrials for the #TheraP trial (NCT03392428)! Just published in Lancet: https://t.co/DySSGVlGFp. Amazing accomplishment comparing to a real control (cabazitaxel). Still waiting for OS, but PSA50RR (66% vs 37%) and rPFS (HR 0.63) favored 177Lu-PSMA

[Marco Romano @Neurociencia]

Os cientistas-médicos são membros essenciais da força de trabalho biomédica. A combinação de treinamento científico e habilidades clínicas os posiciona de maneira única para unir as necessidades clínicas às atividades de pesquisa.

[Carlos Buchpiguel @buchpiguel]

@Neurociencia Perfeito Post Marco. Fully agreed. Abs

[Carlos Buchpiguel @buchpiguel]

@rocharadiologia @CBRadiologia Sucesso aos membros da nova diretoria.

[Carlos Buchpiguel @buchpiguel]

@Felipegaliza @DrMHofman @PeterMacCC @gu_onc @Inrad_hcfmusp Great Felipe. Thanks to Prof. Hoffman for sharing his incredible and outstanding expertize on PSMA Theranostics.